ArticleIn vivo (Athens, Greece)

Three-month Prostate-specific Antigen Level After Androgen Deprivation Therapy Predicts Survival in Patients With Metastatic Castration-sensitive Prostate Cancer.

Naohiro Fujimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.